Biomarkers are molecules of biological processes that help in both the diagnosis of human
diseases and in follow-up assessments of therapeutic responses. Biomarkers can be …

Biomarkers are molecules of biological processes that help in both the diagnosis of human
diseases and in follow-up assessments of therapeutic responses. Biomarkers can be …

This chapter focuses on providing a brief overview of using saliva for the discovery of
potential biomarkers for the diagnosis of Alzheimer's disease (AD). In contrast to blood and …

A major drawback for biomarker research on neurodegenerative diseases is that the
pathologically affected tissue, ie, the brain, cannot easily be accessed for sampling or …

Neurodegenerative and neurodevelopmental diseases represent neurological disorders
that variably affect individuals and produce negative consequences, such as altered social …

Alzheimer's disease (AD) is becoming a threat to aging population all over the world. The
pathogenic process of AD is likely initiated many years before clinical onset, thus biomarkers …

Background. The histopathological changes of Alzheimer's disease (AD) are detectable
decades prior to its clinical expression. However, there is a need for an early, inexpensive …

The search for accessible and cost-effective biomarkers to complement current
cerebrospinal fluid (CSF) and imaging biomarkers in the accurate detection of Alzheimer …

Background: The metabolomic and proteomic basis of mild cognitive impairment (MCI) and
Alzheimer's disease (AD) is poorly understood and the relationships between systemic …

Many neurological diseases are characterized by progressive neuronal degeneration. Early
diagnosis and new markers are necessary for prompt therapeutic intervention. Several …